首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1647515篇
  免费   138891篇
  国内免费   6244篇
医药卫生   1792650篇
  2018年   16684篇
  2016年   14652篇
  2015年   17655篇
  2014年   23891篇
  2013年   34449篇
  2012年   47222篇
  2011年   49562篇
  2010年   29739篇
  2009年   28017篇
  2008年   45954篇
  2007年   48118篇
  2006年   48676篇
  2005年   47047篇
  2004年   45593篇
  2003年   43506篇
  2002年   42352篇
  2001年   76483篇
  2000年   79020篇
  1999年   67109篇
  1998年   18155篇
  1997年   16756篇
  1996年   16668篇
  1995年   16309篇
  1994年   15331篇
  1993年   14370篇
  1992年   55579篇
  1991年   53904篇
  1990年   52690篇
  1989年   50926篇
  1988年   47310篇
  1987年   46631篇
  1986年   44352篇
  1985年   42880篇
  1984年   32024篇
  1983年   27548篇
  1982年   16102篇
  1981年   14388篇
  1980年   13500篇
  1979年   30425篇
  1978年   21032篇
  1977年   17697篇
  1976年   16650篇
  1975年   17523篇
  1974年   21457篇
  1973年   20650篇
  1972年   18848篇
  1971年   17754篇
  1970年   16277篇
  1969年   15257篇
  1968年   13937篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Existing methods for estimating additional days of hospital stay due to nosocomial infections (NI) have a number of documented limitations. An alternative method described in this paper uses the Appropriateness Evaluation Protocol (AEP) to determine whether each day of acute inpatient care is appropriate based on the need for care of the NI, original cause of hospitalization (OC), or combined NI-OC requirements. Using this method to identify specific days of hospitalization due to Staphylococcus aureus nosocomial infection, we find: 1) length of stay is increased for only a minority of patients (38%); 2) an average of 20 additional days of stay occurred for patients with 1 or more days attributed to NI; and 3) an average of 52% of length of stay of patients with 1 or more days attributed to NI can be attributed to the NI. Application of the AEP-based method is a useful alternative for identifying additional days of stay due to NI.  相似文献   
993.
The in vitro activities of beta-lactam antibiotics against Bacteroides fragilis and B. fragilis group isolates are presented. Clinical isolates from 1986 were compared with strains from 1979 to 1982. Imipenem, ticarcillin-clavulanic acid, and ceftizoxime were the most active agents. Cefotetan was equivalent to cefoxitin against B. fragilis but less active against B. fragilis group isolates. Enhancement of cefotaxime by its desacetyl metabolite was minimal.  相似文献   
994.
Pregnancy-induced hypertension (PIH) can be complicated by maternal or fetal thrombocytopenia, or both. In order to investigate possible immunologic causes of these thrombocytopenias, platelet-associated IgG (PAIgG) and IgM (PAIgM) were measured in mothers with PIH and in their infants and compared with those from patients with autoimmune thrombocytopenic purpura (ATP), a known immunodestructive platelet disorder. Many PIH patients (33.3%) and most ATP patients (68.1%) had elevated levels of maternal PAIgG. In both diseases, the amount of PAIgG was directly proportional with the degree of thrombocytopenia (r = 0.446 in PIH and R = 0.668 for ATP). But in neither disease did the degree of maternal thrombocytopenia correlate with the degree of neonatal thrombocytopenia (r = 0.153 for PIH and R = 0.175 for ATP). Umbilical cord samples from PIH patients contained PAIgG (53.3%) and PAIgM (53.8%), whereas the umbilical cord samples from ATP patients had elevated amounts of PAIgG but not PAIgM. PAIgM in the umbilical cord blood could not be accounted for by IgM rheumatoid factors, IgM-containing immune complexes, or non-specific adsorption because of elevated total IgM levels. The umbilical cord blood PAIgM was probably not of maternal origin because it was observed even when the maternal blood contained no PAIgM and maternal IgM is not normally transported transplacentally. Therefore, the PAIgM appears to be of fetal origin. These results suggest that both maternal and fetal immunologic mechanisms may be involved in PIH-induced thrombocytopenia; if so, this is one of the first reported examples of a possible fetal autoimmune response.  相似文献   
995.
996.
997.
998.
An endoscopic endonasal approach was performed to remove an intra-suprasellar Rathke's cleft cyst. Rathke's cleft cyst are benign lesions, rarely diagnosed because they are often asymptomatic. To the best of our knowledge, at least 475 cases of Rathke's cleft cysts have been reported. They seem to arise from remnants of Rathke's pouch, an invagination of the stomodeum. A 52-year-old woman, complaining of bilateral frontal headaches, was operated on by using an endoscopic endonasal approach, for an intra-suprasellar tumor. The pre-operative diagnosis was non-functioning pituitary adenoma. Intra-operatively a creamy-coloured viscous tissue was found. After the removal of the cyst contents and of the capsule, the suprasellar structures were seen well. The chiasmatic cistern, the chiasm, the pituitary stalk and the pituitary gland were visualized with 0 and 30 degree endoscopes. The pathological findings showed a well-differentiated cuboidal epithelium. The diagnosis was Rathke's cleft cyst. No post-operative complications were observed. The endoscopic technique was particularly suitable in this case, both for the Rathke's cleft features and for an excellent outcome. The Rathke's cleft cyst was easily removed by suction and the cyst wall was entirely removed with curettes and pituitary punches. The hypophysis was distinguished from the cyst and was preserved. The surgical manoeuvres were all done under direct visual control. The absence of nasal packing and of breathing difficulties made comfortable the post-operative outcome. Thus, the endoscopic endonasal approach can be considered the favourite technique in case of either intra- and/or suprasellar Rathke's cleft cysts.  相似文献   
999.
秦立篷  李丁  张菊  韩锋产  阎小君 《医学争鸣》2002,23(14):1295-1297
目的:克隆幽门螺杆菌ureB基因,并进行表达,验证表物的反应原性。方法:应用PCR技术从技术临床分离株中扩增出ureB基因,克隆入载体pGEM-7zf( )进行测序,进一步转到友大肠杆菌表达载体pBV220进行诱导表达,以Western blot实验验证重组蛋白的反应原性。结果:测序后经同源性比较,证实扩增后得到的片断确为ureB基因,并原核表达出可被抗Hp抗体识别的非融合重组蛋白。结论:获得了有反应原性的重组ureB蛋白。  相似文献   
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号